Domalagan, Bb Girl -.
HRN: 22-33-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
AMPICILLIN 500MG (VIAL)
12/18/2022
12/25/2022
IV
135mg
Q12
NB Affected By Maternal UTI
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes